Document oebZyoB01x5xgzdNkZjZwb3X3

DownloadRandom document
. ef IM General Ottices 3M General Offices . roms C6 pa pn SSM rComer seston 3M Center St. Paul, MN 55144-1000 FlgE _O0H 1A-R0R 232763_1038 612733 1110 MR Ge SSeepptteemmbbeerr 55,, 22000011 Document Processing Center (7407) Document Processing Center (7407) OOffffiiccee ooff TTooxxiicc SSuubbssttaanncceess USS. Environmental Protection Agency U.S. Environmental Protection Agency 440011 MM SSttrreeeett,, SSWW. Washington, DC 20460 Washington, DC 20460 Attn: TSCA Section 8(e) Coordinator Attn: TSCA Section 8(e) Coordinator BEHO-20-37 2 600 Bl Dl hd 2 DDeeaarr SSeeccttiioonn 88((e)) DDoocckkeett CCoooordrdininataotor:r: Re: TSCA (6) Supplemental Notice on Sulfonate-based Fluorochemicals Re: TSCA 8(e) Supplemental Notice on Sulfonate-based Fluorochemicals W`Wiitthh tthhiiss lleetttteerr,, 33MM iiss pprroovviiddiinngg ffiinnaall rreeppoorrttss aanndd ootthheerr ssuupppplleemmeennttaall iinnffoorrmmaattiioonn rreellaatteedd ttoo pprreevviioouuss TTSSCCAA SSeeccttiioonn 8((ee))nnoottiiffiiccaattiioonnss.. MMaannyyoofftthhee eenncclloosseedd iitteemmss aarree aannaallyyttiiccaall rreeppoorrttss pprroovviiddiinngg bblloooodd sseerruumm aanndd lliivveerr lleevveellss ooff tteesstt mmaatteerriiaallss ffoorr wwhhiicchh tthhee iinn--lliffee rreeppoorrtt rwreehffeeerrrrreiintnghgettoo8(aacdd)mmnionintiiissfttieecrraeetdidodndoocssoeensssihhsaatssedaallorrefeaapddryyelbbieemeeinnnassruuybbdmmaititattt,eedwdettooattrhheees88u((bem))itddtooiccnkkgeetat.. fiIInnnaloottshhteeurrdyccaarsseeepssort. where the 8(e) notification consisted of preliminary data, we are submitting a final study report. Docket AR-226. We believe, however, ha placing these tems in the 8() docket may allow AAllll ooff tthhee eenncclloosseedd iitteemmss aarree aallrreeaaddyy iinn EEPPAA''ss ppoosssseessssiioonn aanndd aavvaaiillaabbllee iinn TTSSCCAA Docket AR-226. We believe, however, that placing these items in the 8(e) docket may allow ffoorr mmoorree ccoonnvveenniieenntt aacccceessss ttoo iinnffoorrmmaattiioonn ddiirreeccttllyy rreellaatteedd ttoo pprreevviioouuss 88((ee)) nnoottiiffiiccaattiioonnss bbyy 33MM.. TThhee ttaabbllee bbeellooww ilissttss tthhee eenncclloosseedd iitteemmss aanndd rreeffeerreenncceess tthhee ssttuuddyy oorr ddaattaa wwhhiicchh aallrreeaaddyy hhaass bbeeeenn tthhee ssuubbjjeeccttoofaf ann 88((ee)) nnoottiiffiiccaattiioonn bbyy 33MM:: AAttttaacchteedd SSiubbamlivssiicona Related Study/Data Already Filed Under 8(c) Related Study/Data Already Filed Under 8(e) 1. 1. lAAfmmoeennnaddmeeidddAAonynaa<llytythtiiaccanalloSSittnuuddTyyw,,o220(GN4en-EEetrthhaltypilpeoenrrlRfluautoorrRooeoopcrctouadnnueection,|| CCDoeovmmeblbioinnpeemddenOOtrraaalll a((GnGdaavrPaaeggreie)n)aFFtaeelrtrPiloiisty,i,natl MsDDueSeitStfeeo6rrn,mmaiPminnFaiatdOtiioSoo)Ann-eAoot,hfftathanhneoedlPPiPrnreeFTssOeewnSnoccAeeGiaaennntddherCCaLootiinnovctneeernRntaartnatidtRiooePnnpFroOoofSfd,PPuFFcOtOiSoS.n,,|| DRREeIeeppFvrreOoolSdoduEpucmctitniieoonRnnatatTTlso,oaxxn3idicMciiPttyReyerSSifntueuardtdeayynl/cPooefofNsNNotn.--atTa-l MCMMi3.55655C66,D,, BPPPFFEROOOVSSSAAAARAAA,P,,laPPunFFsdOORPSSaFAtAOsaaSEnnAxddpoiEEnsXtFetFhOdOeS0SLEEiE-.vOGeOrFHHOaniiSnndEtt-PhhOeFeHOSS,See3r,raMooff || s6E63u31t6Fb1.5Om6,i.S5JtE,euJdiunnnFeReeba33rt00su,,,a3r119M y999199R5,,,efu2fuel0lrl0err0neepcpoeortrN.t o. T- | CRCReRrefIfN:eeCUrreeD2nn0Bcc9eeR5NNV,ooA..JFuT"1n-/"P6e-3l6u131s611.6,R3.25,a0,t0sAA1nE.naxalylpytotisicceaadlltRRoeepEpotorFrtOt TTSOOEX-XO0-H1013,3.3,M || supplement aris fling submitted February 15, 2000 supplement earlier filing to LRN-U2095, June 11, 2001. Cc Ban . OoonnNtttaaaijiinn NNOO OcgB)I ~3 2S8R =2 3388 @ Exhibit 8 p- ! aoosi22t77m88n99 0 | verowssss MET 0438638 227788991.00000011 TTSSCCAA SSeeccttiioonn 88((e)) DDoocckkeett CCoooorrddiinnaattoorr . PPaaggee 22 AtasheloSemois Attached Submission || RReellaatteeFddilStetduutdUyny/dDDeaartaa30AAtlrreeasdtyy | Filed Under 8(e) 12. AAnnaalylyttiiccaall LLaabboorraattoorryy RReeppoorrtt,, DDeetteerrmmiinnaattiioonn oofftthhee CCoommbbiinneedd OOrraall ((GGaavvaaggee)) FFeerrttiilliittyy,, | 1 DeveiandoeprpamabPeosnpa a| SPPPeeerrerrffsulleumunoocrraeoonoodaccnttLdaainnvCeeessoruanulofclfoef_onSnntpararatteateigo((unCCeAoA-fSSDaPNNwoulutmaembsysebireu:rmR:a22t7s755E99x--p33o99-s-3e3)d) iitnno tthhee || RDRineeepRpvrareotolsdod,upucAmctrtiiegoonunntsaTTlRooaexnxsidieccaiiPtrtyeycrhSSinttLauuatddbayoylor/PoaftofosPPrtFinFeOaOsSt,Sa.l || | PSPFeRrOOuSSmvvaiinaadGGaLavivavagegere,o, fLLSaabpbororaragatutooerr-yyDaRRweepploeoryrtt NNoRo.a. tUUs22E00x00p66o,,sed to | nc. Sponsor's Study No. 6295.9 fune | in Rats, Argus Research Laboratories, Inc., Sponsor's Study No. 6295.9, June Reesor res No. STON 63959, eter 21,19. | 1: 159. ulrepo suomi Requestor Project No. 3M TOX 629~.9, October 27, 1999. 10, 1999, full report submitted | Finan 15: 3000 pene February 15, 2000 supplementing 3. RReeppoorrtt AAmmeennddmmeenntt 1|,, CCoommbbiinneedd OOrraall ({GGaavvaaggee)) FFeerrttiilliittyy,, | eeaarrlliieerr ffiilliinngg fons oA ao thi Developmental and PerinataUPostnatal Reproduction Texiy Syof PROS Rats, Ars Reach Toxicity Study of PFOS in Rats, Argus Research Laborer Ie Fron 1508, Sponsor's Sy No. Laboratories, Inc., Protocol 418-008, Sponsor's Study No. 3555. Ap 15, 3000 6295.9, April 13, 2000. 4 AvailRepor,DetermoiftnhParotseionnd |13-WeekDietary Study of Motil Analytical Report, Determination ofthe Presence and CCoonncceenntrtraattiioonn ooff PPeerrfflluuoorrooooccttaanneessuullffoonnaattee,, PPeerrfflluuoorrooooccttaanneessuullffoonnyyllaammiiddee,, MM555566,,aanndd MM557700 iinn tthhee Ever ndSer Samples Environmental Labosoy |63141, Cores Std No. 6329-335, Liver and Sera Samples, 3M Environmental Laboratory Ret No. 3536, TORO, Fea 35,3001 GTayted4u.n3e00500, 3000, Senton 3 ling Ref. No. U2636, TOX-028, February 23,2001 13-Week Dietary Study of N-Methyl PPeerrfflluuoorrooooccttaanneessuullffoonnaammiiddoo EEtthhaannooll ((NN--MMeeFFOOSSEE)) iinn RRaattss,, 33MM RReeff.. NNoo.. TT-- 6314.1, Covance Study No. 6329-225, dated June 30, 2000, Section 8(e) filing July 24, 2000 5 Amaya Laboratory Report, Determinatofiohen |FinalRepar Onl Govege) Analytical Laboratory Report, Determination ofthe CocFOSoFROn SA,PRi OSAAn andEFo OSE: | DevelToox,pSumdyoef0n5 Concentration ofPFOS, PFOSA, PFOSAA, and EtFOSEOe teSor and LiverofCRCDBR VATPls Ras | Biwlpaaroscaneuforamidon OH in the Sere and Liver of CrI:CDBR VAF/Plus Rats Brposcio NEFOSE, M Enirenmenal Lavoro | hon m Ra Melee No. T- Exposed to N-EtFOSE, 3M Environmental Laboratory Raper, TORO, Laborer Rosen No. L403 3. | 6316.7, December 17, 159, submited Report No. TOX-098, Laboratory Request No. U2402, 3M NaF No T4316 Feary 6.3001 tp o SeoniSap docket or rer of | Ref. No. T-6316.7, February 6, 2001. Final Report, Oral (Gavage) Developmental Toxicity Study of 2(NEthylperfluorooctanesulfonamido)ethanol in Rats, 3M Reference No. T6316.7, December 17, 1998, submitted to Section 8(e) docket per letter of & Avatvical LabororyReporon heDrennan ofthe _| Fira Repr, Oral Somach Tae) Analytical Laboratory Report on the Determination ofthe En Deveopmeal Tous Say ors Presence and Concentration of Potassium Feoomsancautomme (PROSor sheemetbol of |EFOSE in Rabbis Reference No. Perfluorooctanesulfonate (PFOS) or another metabolite of Soappeuoroaesiomdihooyl (| T6316, Tamary 11 1999, brid 2(N-ethylperfluorooctanesulfonamido)-ethanol (NEIFOSE) m Liver andSerum Sprimens to Section 50) docket ur ie of EtFOSE) in Liver and Serum Specimens, 3M Enwionmena LabomoryRepos io TOX.91. periie Environmental Laboratory Report No. TOX-097, Eaborsory Ren io 2655 3M RefNo. T4316, Laboratory Request No. U2452, 3M Ref. No. T-6316.8, Fobra 8,201 February 8, 2001 7 Final Repo, Alsandr, B. Moraly rues of Workers| Freliminay aa sabi to Scion Final Report, Alexander, B., Mortality Studies of Workers Emalovesathe of Deas Fact, Univerosf | 56) docks in er of Dacor 15. Employed at the 3M Decatur Facility, University of Nimnsna. Ape 26, 001 ES Minnesota, April 26, 2001. August 21, 2000 Final Report, Oral (Stomach Tube) Developmental Toxicity Study of NEtFOSE in Rabbits, 3M Reference No. T-6316.8, January 11, 1999, submitted to Section 8(e) docket per letter of August 21, 2000 Preliminary data submitted to Section 8(e) docket in letter of December 15, 2000 : 2 ver orssess MET 0438639 22778899..00000022 TTSSCCAA SSeeccttiioonn 88((e)) DDoocckkeett CCoooorrddiinnaattoorr PP,aaggee 33 T Avached Submi-sion [sont ReedsSttyDaas ready Attached Submission Related Study/Data Already Filed Under 8(e) + Fr Report. Act Or Tox Srv wth T3ICAC| Acs Or Tory Semin 7. Final Report, Acute Oral Toxicity Screen with T-3290COC inane Rn Ss Evan Lavoro ie | eo py Sere wit in Albino Rats, Safety Evaluation Laboratory, Riker Cari, ne Fede OVARCHES SM Recess | Boman Lo Laboratories, Inc., Project No. 0882AR0362, 3M Reference NNoo.. TT--33229900 ((4400 %% KI~'+PPFFOOSSAAAA iinn 33 %% EEttOOHH,, 1177% I% PIPAA RAS L418 FOV Lot nemo | henSST RN and 40 % H20, L-6778, F-6873, Lot 501), November 5, Tov logo ery Doct Re kort | 00 0K BE Se 1982 [Bibliography entry in Docket AR-226, final report || a Dee S6r0i7i5nweLmcoeSIsroosnoinonlnosetrocskaaoviiss | was to be moved to TSCA 8(e) docket] Acute Oral Toxicity Screen with T3290COC in Albino Rats, Safety Evaluation Laboratory, Riker LLaabboorarattoorriieess,, IInncc..,, PPrroojjeecctt NNoo.. 0882AR0362, 3M Reference No. T3290 (40 % K~PFOSAA in 3 % EtOH, 17 % IPA and 40 % H20, L-6778, F6873, Lot 501), November 5, 1982, submitted to Section 8(e) docket in August 21,2000 self-audit letter (which erroneously refers to rabbits rather than rats) 5 Gio, nd. Kannan Accumnionf rtm do ebm Soin | Giesy, J.P., and K. Kannan, Accumulation of Femmes od Raat aswel n | mane aT Perfluorooctanesulfonate and Related Fluorochemicals in Be Fish Tissue, Michigan State University, June 20, 2001. Preliminary data submitted to Section 8(e) docket May 26, 1999 10. Gi, 17, sd K. Kann, Aumont 10. Giesy, J.P., and K. Kannan, Accumulation of Pemasamenlom ed em arachenicl a MPMieirnnfkkluaaonnrddooRRcitiavvenerresOOuttltfteoernrs,a,tMMeiaiccnhhdiiggRaaennlaSSttetaadtteeFUUlunniovirveoercrshsieittmyy,,icJJauulnnseein2200,, oo2001. 1 . ley, 12, and K Kaan, Petursctncifnnsd II. Giesy, J.P., and K. Kannan, Perfluorooctanesulfonate and Re Fite ya oer me. Related Fluorochemicals in Oyster, Crassostrea Virginica, Fm he Coffs apes poy Mn From the Gulf of Mexico and Chesapeake Bay, Michigan Se Uaveny 30. 30 State University, June 20, 2001. 1122.. GGiieessyy,, JJ..PP..aannddKK.. KKaannnnaann,, PPeerrffluluorooroocotcatnaensuelsfuonlfaotenaaanntdde RReellaatteedd FFlluuoorroocchheemmicicaallss iinn FFiisshh--EEaattiinngg WWaatteerr BBiirrddss,, Michigan State University, June 20, 2001. Pr -- 13. Giesy, J.P. and K. Kannan, Accumulation of Perhuoraoeincsifonae nd Reled rarochemicas in| Perfluorooctanesulfonate and Related Fluorochemicals in Vine ms i Se Cane acs | Marine Mammals, Michigan State University, June 20, Yar | 2001. IIff yyoouu hhaavvee aannyy qquueessttiioonnss aabboouutt tthhiiss ssuubbmmisisssiioonn,, pplleeaassee connttaacctt mmee at (6511))773377--44779955.. SSiinncceerreellyy,, .m J Geol adamsLone Maannaaggeerr,, 33MM CCoorrppoorraattee PPrrooduucctt Reessppoonnsisbibililiittyy EEnncclloossuurreess . 3 22778899..00000033 So MMEETT 00443388664400 i. L774, F-aF73 ,: RsR 167 [RREECSEEWETD| AAccuuttee OOrraall TTooxxiicciittyy SSccrreeeenn vith m-3290000 with T-3290COC in atbine mats in ~tlbino Rats {iHE wil Ln Experipent No.: ~pe riment No.: ossanoss2 0882AR036 2 Conducted at: Conducted At: RsFSSeiiaa.kkfteeeerrttRyyaLLuaaEP,bbvvooaarrmllaaiuuttnaaootntrrieiiiosoeenonsst,,aLLaabbIToonncerr..aattoorryy St. Paul, Minnesota DDaatteess CCoonndduucctteedd:: JJuullyy 3300,, 11998822 ttoo AAuugguusstt 2277,, 11998822 CCoonndduucctteeda BByy: 4ed@-Fo-373 H75H.1..5S5.L.abTRRohorouddaaoetssoorey smefnnoicinans iHcfes fithaiciiaditia Jr. Laboratory T~chnician Acute Toxicology D oT e Tarior,Conrandeo3n sweift MDTS.ooerxaMdiy.scooMtlDaooirggrkiieosecettt,orJr., BS I Dat~ Study Director RReevviieewweedd BByy:: ac mm. case M. T. C~se Xi. wens K. L. Ebbens TE we FWW... CDC... MGMccrCCioofrrfmmiiitcchkk fifi 00000088111188332218~ SKE.enSiD.or: a O'TMoamlielceo{ys,esiBasSet~ Sreentieor TToomxeioctoolnogyist Acute Toxicology Gy een l Date Co: . ais H - 3 & --_-- even MET 0438641 22778899..00000044 1 Summary Summary An acute oral toxicity screen with -3290C5C wes conducted from An acute oral toxicity screen with T-3290COC was conducted from uJullyy 3300,, 11996822 ttoo AAuugguusstt 2277,, 1962 at Riker 1982 at Riker Laboratories, Laboratories, Inc., Inc., St. St. Paul, Paul, Minnesota using pale and female albino rats ranging in body weight from Mi.nnesota using male and female albino rats ranging in body w~ight from 209-269 grams. The test article was administered by gastric intubation at 209-269 grams. The test article was administered by gastric intubation at a dose level equivalent to 200 mg/kg and 1250 ng/kg body weight with 0/10 a dose level equivalent to 200 mg/kg and 1 250 mg/kg body weight with 0/10 mortalities noted at the 200 mg/kg dose level and 5/10 mortalities noted at mortalities noted at the 200 mg/kg dose level and 9/I 0 mortalities noted at tthhee 11225500 mmgg//kkgg ddoossee lleevveell.. The untoward behavioral reactions which T~e untoward behavioral reactions which ooccccuurrrreedd dduurriinngg tthhee 2286 ddaayy oobbsseerrvvaattiioonn period period at at the the 200 mg/kg 200 mg/kg dose dose level level consisted of hypoactivity fram 60-120 minutes post dose adninistration. consisted of hypoactivity from 60-120 minutes post dose administration. he 1250 mg/kg dose level exhibited hypoactivity, ataxia, diarrhea and, in The 1250 mg/kg dose level exhibited hypoactivity, ataxia, diarrhea and, in the feaales, unkempt appearance. Recovery was generally precluded by the females, unkempt appearance. Recovery was generally precluded by Geath. Body weight gains were noted in all animals which survived the death. Body w~ight gains w~re noted in all animals which survived the study. decropsies perfomed at termination of the study revealed no study. Necropsies performed at termination of the study revealed no Visible lesions, however, autolysis precluded evaluation of three 1250 visible lesions, however, autolysis precluded evaluation of three 1250 magg//kkgs ddoossee lleevveell aanniimmaallss wwhhiicchh ddiieedd prior prior to to the the end end of of the the study. study. The The approximate oral LDSO of 1-3290CSC is greater than 200 mg/kg and less than approximate oral LD50 of T-3290COC is greater than 200 mg/kg and less than 11225500 mngg//kkgg iinn ffaasstteedd pale male and and female female albino albino rats. rats. IInnttrroodduuccttiioonn he objective of this study was to approximate the acute oral LDSO of The objective of this study was to approximate the acute oral LD50 of 7T--332299000C0OC iinn ffaasstteedd aallbbiinnoo rraattss.. This study was conducted for research and This study was conducted for research and development purposes and is, therefore, not regulated by the Food and Drug development purposes and is, therefore, not regulated by the Food and Drug aAdnmiinniissttrraattiioonn''ss GGoooodd Llaabboorraattoorryy Practice Practice Regulation Regulation of of 1978, 1978, although although the the standard operating procedures of this laboratory adhere to the general standard operating procedures of this laboratory adhere to the general principles of this regulation. The raw data generated by the Study principles of this regulation. The raw data generated by the Study Director and the final report are stored in the conducting laboratory's Director and the final report are stored in the conducting laboratory's aarrcchhiivveess.. < 22778899..00000055 NET osa8s42 MET 0438642 2.2 o veshon ana mesuits Method and Results YYoouunngg aal1bbiinnoo xraattss~ vweerree uusseedd iinn tthhiiss tteesstt.. AAlLl aanniimmaallss vweerree hheelldd uunnddeerr quarantine for several daye prior to testing vith only animals whch appeased quarantine for several days prior to be in good heslth and suitable to as testing with test anisals oantlythaeniimnailtsiawthiiocnh oafpptehaered to be study in good health and suitable used. The rats were housed as in stuessptenadneidm,alswiraet-stehseh icnaigteisatiinon of the study used. camperature a The nd rats w~re housed humidity controll in ed rsouosmpsenadnedd,pewrimriet-tmeedsha csatgaensdairnd laboratory temperature and humidity controlled rocks and permitted a standard laboratory daiieettb pplluuss vwaatteerr aadd lliibbiittuums eexxcceepptt dduurriinngg tthhee 1166--2200 hhoouurr ppeerriioodd iimmmmeeddiiaatteellyy pprriioorr ttoo ggaassttrriicc iinnttuubbaattiioonn wwhheenn food food vas vitHheld. was withheld. he rats wre administered the test material at 200 83/kg and The rats were administered the test materialc-- at 200 mg/kg and 1250 ng/kg body eight. ALL doses vere administered wndiloted dizectly into I 250 mg/kg body the stomchs of weight. the rats uAslilngdoaseshypwoedreermaidcmisnyirsitnegreedcquunidpipleudtedWitdhiraectly into the stomachs of the rats using a hypodermic syringe equipped with a bbaatlil--ttiippppeedd iinnttuubbaattiinngg nneeeeddllee~dd,. Acer gustric sdsinistration of the est article, the rats were returned After gastric administration of t~e test article, the rats w~re returned to their cages and observed for the following 28 days. Initial, 14 day and final to their cages and observed for the body weights, mortalities (Table 1) afnodlloawdivnegrse28 rdeaaycst.ionsIni(tTiaabll,e 114) dvaeyrsand final body weights, mortalities recorded. A necropsy vas (Table I) conducted oanndalaldvaenrismealrseactthiatonsdie(dTadbluerinIg) wtehere study recorded. A necropsy was conducted on all animals that died during the study a6 wll as those euthanatized and the end of the 26 day cbaervation period as well as (mble 1). Tethose euthanatized and the end of protocol, principal personnel the in v 28 day olved i nobtsheervsattuidoyn, period (Table I ). composition The protocol, principal personnel involved in the study, characteristics and guality Mesurance statement are contained in composition characteristics and Quality Assurance statement are contained in sepenices - Tv. Appendices I - IV. 2 king zave, oregon, a Taliton Purina Laboratory crow, Ralston purine, St. louis, Ho ~ King Labs, Oregon, WI --Ralston Purina Laboratory Chow, Ralston Purina, he `test arvicic i 40% s0Lids and was dosed at 200 mo/ks ana 1250 ma/kg of ~ The test article is 40% solids and was dosed at ssoolliiddss wwhhiicchh iiss eeqquuiivvaalleenntt ttoo aann uunnddiilluutteedd ddoossee "as is", respectively. 4 oper nd Somes ew ide asi, WY ~ popper and Sons, New Hyde Park, NY St. Louis, MO 200 mg/kg and 1250 mg/kg of ooff 550000 mmgg//kkgg aanndd 3125 3125 mg/kg mg/kg 66 _-- TT eronee MET 0438643 22778899..00000066 3. TTAABBLLEE 11 AACCUUTTEE OORRAALL TTOOXXIICCIITTYY SSCCRREEEENN - = AALLBBIINNOO RATS RATS wwiitthh TT--33229900CCO0CC MMoorrttaalliittyy,, NNeeccrrooppssyy,, AAddvveerrssee RReeaaccttiioonnss aanndd BBooddyy WWeeiigghhtt DDaattaa (DDsooass/eekg-a)- Sex ANAnuniimmmbaaellr (m22g00/00k9) SeuMxw N22uRmm33b5see8rr7 283588 2R222RRR3333555588989809 222R8R333555999110 220000 F 2228RR333666000877 22228R8R3333668600109980 2228RR333666111110 11225500 Mom 22a8R33m5599s32 22228RR3333555599995434 2228RR333555999566 11225s00 FFo 22mR33e6611z32 222R8R333666111443 222R8R333666111655 2R3616 ITnnddiiTvviieddsuutaallDayBSoeddNyyumbWWeeeri:gghht~ss (3) (g) o0Test Day1144Number:2288 52255133 223990336 33352:188 222256661388 333302208689 333354661699 22666232 33301090 33346969 222221556 222666333 222666990 22221112996 222263433166 222255652027 222112982 222433515 222445979 222666055 (((Dvaaayyy 77))) 222266669033 (((DcDa3aayy0y3655))) 367 222666922 ((vD3aa0yy366)) 367 222112772 (aaDyyay 554)) 222211216624 (Ga(DDaaayyyy 4555)))) 222001994 (((DDaaayyy 353))) SNuN,mu,bs-TebbreerrTeDDesetaaeddd Number Tested o0r/s5 oo//s5 a4s/s5 5/5 5/5 pPeerrDcceeeanndtt Dead 0 88O0 100 IO0 ~ZhThee tteesstt solids, Oaafrrttwiihccillceeh wwtaahsse aatddemmsiitnniiassrttteeirrceeldde uucnnoddniislliuusttteesdd.~ ohfhooww4ee0vv%eerrs,,olittdhhsee. ddoossee rreepprreesseennttss mgs mgs of of TT~eesoaalcciuudttsee, ooorrfaallwhLLiDDc5Sh0O tiihsse ggtrreeesaattteearrrtttihhcaalnne 22c00o00nsnmiggs//tkksgg oafnd40l%esssoltihdasn. 1250 and less than 1250 sg/ky mg/kg in in fasted fasted sale male aaNonntdde:ffeesmaaFllieegurrreaasttss..in parenthesis indicate time of death. NNNNeoeocctcerEr:oeopppsesyiyFeisgupreersfoirnmepdaruepnotnhetseirsm indicate ination r time of ovealed death. no visi ble losions at the 200 Neevcerlo.psieTshepe1r2f5o0rmmegd/kgupodnosetcrlmeivnelatpiroondurccevdcaln~od vniosivbilseiblle~sioln~ssiounpsonatnectrh~ops2y0,0 m/ks dose =hgo/wekvgerd,ose aaluuevtteoolll.yyssiissThpeprree1c2c5ll0uuddmeegdd/keegvvaadllouusaaettiioolnneveoolff ptrhordeueceadnimnaolsv.isible three animals. lesions upon necropsy, however, 7 22778899..00000077 TT MMEETT 00443388664444. Ye 2 J 2- g <89 | 2 i). : |Ed LEEg 3 |82 |- sppi8d 2g. iid 1 8 = Hel s 35 ss p3b8? 3 888 o o o 3 5 8% $e8g 3IT 813% 28 3% eo o 3 1 : ii: o 4J 3~4 g8 i, 0. e 0 -H FI o :8 El 3 oe - ER g : fF iE HE o o -- 0 0 22778899..00000088 Tr 1 gx TT WMEETT o0a4s3s8e6s4s5 Riker Experiment No.i__ 002;?3S33A~2O0I~8-336~22 aepErDIX 1 Riker Experiment No.: 5. PAPRPOEThDOICXOIL PROTOCOL TrEeSsTt: AAecet,orera0rta!esTotxeictite)'y SSPPOONNSSOORR:: 33MM_ CCoom~merrcciiaallCChheenm~iicc;a=lIss CCOONNDDUUCCTTEEDD BBYY:: Safety Evaluation Laboratory, Riker Laboratories, Inc. St. Paul, Minnesota Safety Evaluation Laboratory, Riker Laboratories, Inc., St. Paul, Minnesota DiDviviissiioonn TTEESSTTAARRTTIICCLLEE:: IT--3322900C0oCCC conTROLARTIOLE: Mew: CONTROL ARTICLE: Lk ~< PROPOSEDSTARTINGICOMPLETIONDATE OF Tes: PROPOSED STARTING/COMPLETION DATE OF TEST: fe =fefie TesTSYSTEM: Pig RAT, 5 SRA SOURCE: Kin Legs Clrecon, IN| SNSeuexmx::be:14,r,:FF 45 WNeuimghbterR: an;g~e5: 200-709 srs I ---------- Weight Range: 200-'-,00 gr~s OBJECTIVE: TThhee oobbjjeeccttiivvee ooff hsthis teesstt wwiillllbbee ttoo characterize characterize the the acuta acute a=o--,.-:i toxily of to test toxicity of the test OBJECTIVE: uct aarrtiiccllee iinn oaafllbbriiennsoopoT nse,a zhi-sattt osricals use. , ease _Finah~atandstsing_an_d_genwweeerrreea assveealleleaccbtteiedidy.aass aa tleesstt ssyysstteemm ffoorr rreepprroo-- MMEETTHHOODD:: doTTcCuohhmcneeiritberaaoillnnilatliaieyrmmddiaoalafrrlsso,oreoowwsmiwmlipllisslobbnddbeesuuoerrhhii,nsoonhgugueisssnbbeetoootddtrtehihciindnatthlhssebettuayasqqiienunuc,llaoaeerelrssaoaassnrnstesstciittnoneeidneeeeillnhaagssann,uunddssdapttpleiecenesscngnttoddrppaeedeenddrirdiniowowggiddiersrs1ee,n6, ewmwmtriheaiettehlshsahhl0fvoa0ccaoboada6ilraagg8a-beetisasaolirnntiiyynddn.'stwtweeaasmmtttpeepaerrneordrofaaafflfrteeuudrrrreeeeoddpaaaeannrddddatilhhiibuuntimmgtuiiumddpiir_b.tot-yy-. SSoEcdaeooadadcscqiuaahurggeaeaeet,neiwooilmfhfcyaic"hclhhwawirIillialllcbcct*egooerrrmriitdezoaoeseJsnpkptgtooihfnneiwweddidlilltloobxbbttycheehteecyaaoaaddonlnofmmiirmimtinhancaliossl detnnetirnuuerssemgmtddb,baeeaeerrrcaassccoccoohh,nrndaaiaaancnndgicaidmmairatrtaodldol,,naathafhfhlfeoioxxwweaeleanddevbitvetmoeoorarrt,alt,hhtsoeeiiffrwyoiutth'luhstiitssssbsiiedtGdaeeoonassdoodaafmfaggittrheendhieslloecctepavveeeegralrleead.ddtAgiAoontehggsseessiinnpfgnngr.elooolseel-tt aatSrrhrdsitseiecqalrpeucraoiaahttoteoelcSsyaouurlpcp.pThpTlalheehrmmm eatecetentenetsstratatilzlaaet ddrcttooihcsseeleaaggtwwoeeixilllillsceebbivvutseeyelrslasao.ed.dfmdmAAtihnnnieniyyissttaaetleeddsrrittdeeiidadtoirocntttniogocaalleettlhh,seddeaoo2aadssn0ndaai0iiggmtmieeoacalnlllasseaevlvriieneanleltsnsthhdimewweiiafiflllolsorbbmneowrirdyrdlleeooccbccieeeuuiivmmovaeeededdnnmntfftsireernoddoimsmbtaaettnnerhheddeaedffvssiiltpepheeodoedrnnswwstoeioirtsrhh,,t `aawYacofictltneltoioidrimonunnweccssihilusffeiodocddrerhe.t,tohthnhbueeeutafftloloalnnllnaoooontiwtmwiiibbmnanaeegllgs'~slm3~i4:m~iiwlilhtadtei.~eadbey~hy~t1eo0,d;r;IIiennehthiiuteiediraaanaullerrradta,i,nnndtllgdoufuntinftihggnhnseasea,l,ilcrbilobiocvenodearddrg,yuy,ecwkwktsieioeddiainnggneehhdtyytthsssseobwwaatisennillselddtrbbvgageeeesedrrnneeweefeccrorlooaarlrlrlddaaegegnsdaday.s.stthutrAAreongoigtrianonrnotwoteiesssamssstratidilnnnnsaeaeblclcesrrutthororraaappvccvissttivyyoiwwrwnwaiighlllhlitirccbbehhheeo- vcoctceooesponrctddteedpuodecrrrtiewwo.aiddinlt.hhdoAAnstsnnhppayyeeelclciagiainrrfiiaonocclssimssmm-aeoaaeplnsbbnotrnntwitoooohnrnrwmimictllehaoollbidittteihieeeeesssdtoowwourhrrhrggieiinacadcgnhnhintaaaahrrhneneededc/oooiobbRrnsisskdeseeiirurtrveevceetLOoddoabbfbscdsoeutuehrrrrrveiaivnenledgtgoed.is.tthsthAAe'ealllscAcroorrwacnnahwedwdiluulvcddecataa,tsttooaaStff.hggttehehePeenaaneunennlrireme,aaccttaMrereolioddsnppnsssbbeyuyyysrwwvottihithivlleealinbbsgseettuutrrhddeeeyy-- director and the final report will be stored in the Riker Laboratories' Archive, St. Paul, Minnesota. 2a_ pPuuyriinnaa LLaabboorraattoorryy CChhooww,, RRaallssttoonn PPuurriinnaa,, rBiEesEeFoao rweeidr FE Cw13e0rmnetlneh St. Louis, Missouri FS2ot.rL0ouAis,anMI/kiksss-oo u(riaMs oSkoliPsE)RIsOoDlution *dose at %wc:, le~-e!-~: 1230 r::9!]{~ ~ 200 iso Dusnf iAeT: l LA SpSopnonssoorr 2.2852 Dre cme bn "> DGaattee- SSttuuddyy ODrireeccitoorr Zkwo Date 22778899..00000099 MMEETT 00443388664466 : RRiikkeerr EExxppeerriimmeenntt NNoo..:: 00888822A0R800336622 6. DeviationsAAPPPPaEEnNNdDD/IIoXXr AIIse((nccdoosnnecclnluutddseeddt))o Protocol Deviations and/or Amendments to Protocol 1. s sed solution with 40% solids not 508. I. ~he test article was suDDlied as a solution with 40% solids not 50%. - -_ DSuaeynoiretcetearrban J Study Director v30T/atme2 Dat~ 2.2e _-- SSutugdyolDrireeecttsorr |mDaattee w__ 3m - --- Study Diereector te Study Director Date " - - ee ---------- EE Study pizeceoreeewate Study Director Date s. _ FN SStuuddyy Director EDaSt= Director lo ; 22778899..00001100 TT wMeErTo0m4s38s6a4r7 7. AAPPPPEENNDDIIXX IIIT pPrriinncciippaall Ppaarrttiicciippaattiinngg Ppeerrssoonnnneell IInnvvoollvveedd iinn tthhee SSttuuddyy Name Name H. 5. Rhodes H. S..Rhodes DD.. HM.. MMaarrkkooee,, JJrr.., BBSS XKK-. LL.. EEbobbeennss,, BS BS XK.. DD.. OO''Mkaalllleeyy,, BBSS GG.. cC.. Ppeeccoorree FFuunnccttiioonn JJArrc..uteLLaaTbboooxrraaittcooorrlyyogyTTeecchhnniicciiaann Acute Toxicology TTsootxxuiidcycoollDooiggriiessctttor Study Director STsuuoppxeeirrcvvoiilssooogrry Testing Toxicology Testing sSAeecnnuiitooerrToTTxooxixicicocololologogygiisstt Acute Toxicology sSAuunppieemrravvliissLooarrboratory Animal Laboratory n 22778899..00001111 - - EMETT 00443388664488 8. AAPPPPEENNDDIIXX IT CCoommppoossiittiioonn CChhaarraacctteerriissttiiccss TThhiiss ssttuuddyy iiss nnoott rreegguullaatteedd bbyy the t_he Good Good Laboratory Laboratory Practice Practice Act Act of of 1978 1978 aanndd tthheerreeffoorree iinnffoorrmmaattiioonn ppeerrttaaiinniinngg to to composition composition characteristics characteristics is is not not aapppplliiccaabbllee ffoorr iinncclluussiioonn in in this this study. study. 1 22778899..00001122 TT vMEeT T04o38m64m9 a s. AApPpPEENNDDIIXX ITVV Quality Assurance Statement Quality Assurance Statement TThhiiss ssttuuddyy iiss nnoott ooffffiicciiaallllyy rreegguullaatteedd bbyy the the Good Good Laboratory Laboratory Practice Practice RReegguullaattiioonn ooff 11997788,, aanndd tthheerreeffoorree aa ssttaatteemmeenntt signed signed and and prepared prepared by by the the CCoommpplliiaannccee AAuuddiitt ddeeppaarrttmmeenntt is is not not applicable. applicable. TThhee ssttaannddaarrdd ooppeerraattiinngg pprroocceedduurreess of of this this laboratory laboratory_ does does adhere adhere to to the the ggeenneezraall pprriinncciipplleess ooff tthhiiss rreegguullaattiioonn.. The Compliance Audit dnpartment does The Compliance Audit department does iinnssppeecctt ddiiffffeerreenntt ssiiggnniiffiiccaanntt pphhaasseess ffoorr ssttuuddiieess uunnddeerrwvaayy in in the the Acute Acute TTooxxiiccoollooggyy LLaabboorraattoorryy oonn aa rreeccuurrrriinngg ccyyccllee,, aanndd tthhee facilities facilities are are examined examined on on aa tthhrreeee mmoonntthh sscchheedduullee.. IInn aaddddiittiioonn aa sseelleecctt nnuummbbeerr ooff RReesseeaarrcchh & & Development Development ssttuuddiieess aarree rroouuttiinneellyy ppiicckkeedd aatt rraannddoomm ffrroomm tthhee Archives Archives by by the the Compliance Compliance AAuuddiitt ddeeppaarrttrmeenntt for for review. review. 13 - TT -- 22778899..00001133 TT wMEeTT0o4s38E65e0s0